摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-[(2S)-2-methylpiperazin-1-yl]benzonitrile

中文名称
——
中文别名
——
英文名称
2-chloro-4-[(2S)-2-methylpiperazin-1-yl]benzonitrile
英文别名
——
2-chloro-4-[(2S)-2-methylpiperazin-1-yl]benzonitrile化学式
CAS
——
化学式
C12H14ClN3
mdl
——
分子量
235.71
InChiKey
BNWVDRNYSCCNBJ-VIFPVBQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    39.1
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Ureas having androgen receptor degradation activity and uses thereof
    申请人:ACCUTAR BIOTECHNOLOGY INC.
    公开号:US11220490B2
    公开(公告)日:2022-01-11
    The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
    本公开涉及新型化合物、含有此类化合物的药物组合物及其在预防和治疗癌症及相关疾病和病症中的用途。在某些实施方案中,本文公开的化合物具有雄激素受体降解活性。
  • NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF
    申请人:ACCUTAR BIOTECHNOLOGY INC.
    公开号:US20210300901A1
    公开(公告)日:2021-09-30
    The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
  • [EN] NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF<br/>[FR] NOUVELLES URÉES AYANT UNE ACTIVITÉ DE DÉGRADATION DU RÉCEPTEUR DES ANDROGÈNES ET LEURS UTILISATIONS
    申请人:ACCUTAR BIOTECHNOLOGY INC
    公开号:WO2021061642A1
    公开(公告)日:2021-04-01
    The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
查看更多